FDA Commish asks for more power over compounding

As FDA Commissioner Margaret Hamburg prepared to testify before Congress about the deadly meningitis outbreak, reports surfaced that the agency wanted to shut New England Compounding Center down to fix manufacturing violations in 2003, but deferred to state regulators who apparently dropped the ball. Hamburg was expected to call for broader FDA authority to combat future compounding problems. Report | Report